Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$80.93 - $108.63 $2.21 Million - $2.97 Million
27,332 New
27,332 $2.83 Million
Q3 2021

Nov 15, 2021

SELL
$74.77 - $85.47 $3.62 Million - $4.14 Million
-48,403 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$75.51 - $84.79 $3.65 Million - $4.1 Million
48,403 New
48,403 $4.04 Million
Q1 2021

May 12, 2021

SELL
$74.73 - $90.69 $12.6 Million - $15.3 Million
-169,200 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$72.61 - $90.2 $12.3 Million - $15.3 Million
169,200 New
169,200 $14.8 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.